A novel series of p38 MAP kinase inhibitors for the potential treatment of rheumatoid arthritis.

Dearg S Brown; Andrew J Belfield; George R Brown; Douglas Campbell; Alan Foubister; David J Masters; Kurt G Pike; Wendy L Snelson; Stuart L Wells

doi:10.1016/j.bmcl.2004.08.006

A novel series of p38 MAP kinase inhibitors for the potential treatment of rheumatoid arthritis.

Identifier:nobleid.org/w1/20260515/2C7273EB

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/2C7273EB.svg?ark=w1%2F20260515%2F2C7273EB)](https://nobleid.org/work/w1/20260515/2C7273EB)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

A novel series of p38 MAP kinase inhibitors for the potential treatment of rheumatoid arthritis.

Identifier:nobleid.org/w1/20260515/2C7273EB

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/2C7273EB.svg?ark=w1%2F20260515%2F2C7273EB)](https://nobleid.org/work/w1/20260515/2C7273EB)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work